Oral pharmaceutical composition of desmopressin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8993521
APP PUB NO 20110251123A1
SERIAL NO

12672255

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a liquid oral pharmaceutical composition of desmopressin, and its use for the treatment of central diabetes insipidus, primary nocturnal enuresis, bleeding in patients with Hemophilia A, with von Willebrand-Jürgens disease and postoperative bleeding.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GP PHARM S APOLIGONO INDUSTRIAL ELS VINYETS-ELS FOGARS CTRA COMARCAL 244 KM 22 SANT QUINTI DE MEDIONA ES-08777
LABORATORIO REIG JOFRE S A08970 SANT JOAN DESPÍ

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boix, Montanes Antonio Barcelona, ES 1 2
Carbajal, Navarro Nuria Barcelona, ES 1 2
Garcia, Plumed Cesar Barcelona, ES 1 2
Mis, Vizcaino Ricard Barcelona, ES 4 13
Nieto, Abad Carlos Barcelona, ES 2 2
Parente, Duena Antonio Barcelona, ES 8 51

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 30, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00